Albion Community Power

Albion Community Power, part of Albion Capital Group, is a United Kingdom-based asset manager that specializes in investing in early-stage companies. Founded in 1996, Albion typically invests between £2 million and £5 million for minority stakes in Series A and early Series B funding rounds. The firm primarily focuses on digital B2B companies, particularly in sectors such as enterprise software, technology services, digital health, cybersecurity, marketing technology, and fintech. Companies that align with macro trends, including disruption and digital transformation, are of particular interest. Albion also engages in investments that commercialize intellectual property from University College London through the UCL Technology Fund.

Valerie Aelbrecht

Investment Associate

Leigh Brody

Investment Manager

Adam Chirkowski

Investment Director

Will Fraser-Allen

Managing Partner

Emil Gigov

Partner

Molly Gilmartin

Investment Manager

David Gudgin

Partner

Sebastian Hunte

Investment Manager

Edward Lascelles

Partner

Cat McDonald

Investment Director

Tanel Ozdemir

Investment Manager

Kibriya Rahman

Investment Associate

Christoph Ruedig

Partner

Jay Wilson

Partner

116 past transactions

Pando

Seed Round in 2020
Pando is an essential tool for teamwork and secure collaboration. It is designed to benefit anyone working in health and social care, working in a team, with a need to share sensitive information and images securely.

Symetrica

Venture Round in 2019
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.

Pando

Seed Round in 2018
Pando is an essential tool for teamwork and secure collaboration. It is designed to benefit anyone working in health and social care, working in a team, with a need to share sensitive information and images securely.

Locum's Nest

Venture Round in 2018
Locum's Nest is an online recruitment platform that transforms the recruitment process for locum staff in the NHS. By streamlining the connection between doctors and locum work in hospitals, the platform enables healthcare facilities to efficiently manage locum shifts and maintain essential documentation in one central location. It offers features such as customized job searches, automated record-keeping, and the ability to build vacancy portfolios, ultimately facilitating the hiring of temporary workers. This innovative approach aims to reduce reliance on external agencies and lower costs associated with locum staffing, addressing the financial pressures faced by the NHS while improving the overall recruitment experience.

Arecor

Venture Round in 2018
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in the development of innovative stabilization technology solutions for pharmaceutical and biotech firms. The company partners with these organizations to enhance the commercial value and utility of proteins used in various applications, including vaccines, therapeutic proteins, and treatments for complex diseases. Arecor focuses on developing products for areas such as diabetes, oncology, immunology, and infectious diseases, working to reformulate existing therapies to improve their efficacy and ease of use. Its innovative formulation technology enables high concentrations of antibodies for at-home self-administration and stable liquid formulations for biological therapies. Arecor also addresses challenges related to protein degradation and stability, particularly in the formulation of growth hormones and vaccines. Founded in 2006, Arecor operates primarily in the UK and has a global reach, collaborating with leading pharmaceutical and biotech companies to deliver enhanced therapeutic solutions.

Phrasee

Series A in 2018
Phrasee Ltd. is a London-based company specializing in artificial intelligence-driven marketing language generation. Founded in 2015, Phrasee has developed advanced technology that predicts audience emotional responses and generates effective marketing copy. Its Natural Language Generation system can produce millions of human-like variations, optimizing subject lines for emails, body copy, trigger campaigns, and calls-to-action. By analyzing extensive language data, Phrasee's algorithms ensure that the generated content is tailored to specific brands, enhancing engagement and driving conversions. The company's innovative approach aims to revolutionize digital marketing by leveraging AI to create compelling language that outperforms traditional human-generated copy.

Quantexa

Series B in 2018
Quantexa Limited is an information technology company based in London, specializing in entity resolution and network building technology. Founded in 2016, Quantexa offers solutions that include comprehensive customer and network views, fraud detection, compliance, anti-money laundering, and surveillance. The company's technology leverages real-time entity resolution, network analytics, and artificial intelligence to integrate diverse data sets and enhance decision-making for its clients. Quantexa serves a global clientele across various sectors, including financial services, corporate, and public institutions, and has established a strategic alliance with Accenture. The company operates internationally with offices in the UK, Brussels, New York, Boston, and Sydney.

Hazy

Seed Round in 2018
Hazy Limited is a London-based company that specializes in automatic data anonymization using artificial intelligence. Incorporated in 2017, Hazy develops a platform that generates synthetic data, which retains the statistical properties of real datasets while ensuring the privacy and confidentiality of personal information. This innovative approach allows businesses to share and utilize data for analytics and innovation without the risks associated with compliance and security breaches. By capturing patterns from raw data, Hazy creates entirely synthetic datasets that provide the statistical value of the original data, enabling data-centric organizations to unlock their data potential more safely and efficiently. Hazy is recognized as a spin-out from University College London and has garnered backing from prominent partners such as Microsoft and Nationwide.

uMotif

Venture Round in 2018
uMotif Limited is a healthcare technology company that develops a data capture solution designed for clinical research. Founded in 2012 and based in London, uMotif operates a patient-centered platform that facilitates the collection and validation of various forms of patient-generated data, including electronic consent, electronic clinical outcome assessments, and patient-reported outcomes. This platform enables researchers and clinicians to gather comprehensive health data that is essential for medical research, benefiting pharmaceutical companies, medical device manufacturers, biotech firms, contract research organizations, and academic institutions. By enhancing the data collection process, uMotif supports the advancement of clinical research across diverse health conditions.

Panaseer

Series A in 2018
Panaseer Limited develops a cloud-based cybersecurity intelligence platform that assists enterprise security teams in making informed risk decisions. Founded in 2014 and headquartered in London, with an office in New York, the company offers the Panaseer Security Data Lake, which provides real-time insights into an organization's assets, applications, users, and data sets. This platform identifies gaps in security controls and aligns them with industry standards while facilitating regulatory compliance. By ingesting data from various sources, both cloud-based and on-premises, Panaseer enables organizations to monitor and analyze their cybersecurity posture effectively. The platform automates reporting processes, tailoring insights for stakeholders at different levels, thereby enhancing decision-making across the organization. Security leaders utilize Panaseer’s capabilities to prioritize risks based on their potential impact on the business and optimize overall cyber hygiene practices.

Healios

Venture Round in 2018
Healios Limited, founded in 2013 and based in Southampton, United Kingdom, operates an online platform that facilitates video calls between mental health therapists and patients, including both children and adults. The company focuses on enhancing the delivery of mental health care by integrating technology with specialized expertise and personal connections. Healios aims to empower patients and families affected by mental and physical illnesses through innovative family intervention and behavioral change techniques that extend beyond traditional treatment settings. By fostering a deeper understanding of mental health and promoting healthier habits, Healios seeks to improve patient outcomes and enhance the quality of life for individuals and their families.

Hussle

Series A in 2018
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Koru Kids

Seed Round in 2018
Koru Kids Ltd. is a childcare service provider based in London, United Kingdom, specializing in nanny sharing arrangements. Founded in 2016, the company connects families who have a full-time nanny with those seeking part-time childcare, primarily in Greater London. Koru Kids aims to improve childcare options by facilitating these shared arrangements, which can reduce costs for families while providing flexible care solutions. The team behind Koru Kids possesses backgrounds in childcare, healthcare, and technology startups, indicating a diverse expertise in addressing the needs of modern families. The company is registered with the Information Commissioner's Office and is affiliated with the Financial Conduct Authority's Innovation Hub.

Oviva

Series A in 2017
Oviva is a digital health company providing medically-oriented nutritional counseling services in Switzerland, Germany, and the United Kingdom. Founded in 2013 and headquartered in Ingenbohl, Switzerland, Oviva offers personalized behavior change programs aimed at managing diet and lifestyle-related health issues like obesity and diabetes. Their services are delivered through a network of qualified dietitians who work with clients both in clinics and remotely. The company has developed a smartphone application that allows users to engage with their dietitian, maintain a food diary, set health goals, and access tailored educational materials. This technology-enabled approach helps patients achieve better health outcomes while reducing the need for in-person appointments, ultimately lowering healthcare costs by preventing complications associated with these conditions.

G.Network

Venture Round in 2017
G.Network is the next generation communications service provider exclusively focused on Central London. The company provides affordable ultra-fast (up to 10Gbps) fibre connectivity to businesses. We are building our own ‘Fibre to the Premises’ (FTTP) fibre optic network directly into premises across the Capital meaning we can offer unrivalled quality and speeds at affordable prices. Bridging the gap between constrained copper-based connectivity and expensive, long lead time leased lines, G.Network ‘s fibre–based connectivity will transform the way you do business.

Panaseer

Seed Round in 2017
Panaseer Limited develops a cloud-based cybersecurity intelligence platform that assists enterprise security teams in making informed risk decisions. Founded in 2014 and headquartered in London, with an office in New York, the company offers the Panaseer Security Data Lake, which provides real-time insights into an organization's assets, applications, users, and data sets. This platform identifies gaps in security controls and aligns them with industry standards while facilitating regulatory compliance. By ingesting data from various sources, both cloud-based and on-premises, Panaseer enables organizations to monitor and analyze their cybersecurity posture effectively. The platform automates reporting processes, tailoring insights for stakeholders at different levels, thereby enhancing decision-making across the organization. Security leaders utilize Panaseer’s capabilities to prioritize risks based on their potential impact on the business and optimize overall cyber hygiene practices.

MPP Global

Series B in 2017
MPP Global Solutions Ltd., trading as MPP Global, develops and provides integrated cloud identity management, customer relationship management (CRM), and ecommerce solutions through its eSuite platform. Additionally, it offers metering, marketing, promotion, billing, payment, subscription, reporting, and analytics solutions. The company caters to television, media, publishing, and entertainment industries. Its clientele include Sky, The Times, L''Equipe, The Daily Mail, el Mundo, el Tiempo, Local Media Group, The Irish Times, TP Vision, and Universal Music Group. MPP Global Solutions Ltd. was founded in 2000 and is headquartered in Warrington, United Kingdom with additional offices in Europe, United States, South America, and Australia.

Quantexa

Series A in 2017
Quantexa Limited is an information technology company based in London, specializing in entity resolution and network building technology. Founded in 2016, Quantexa offers solutions that include comprehensive customer and network views, fraud detection, compliance, anti-money laundering, and surveillance. The company's technology leverages real-time entity resolution, network analytics, and artificial intelligence to integrate diverse data sets and enhance decision-making for its clients. Quantexa serves a global clientele across various sectors, including financial services, corporate, and public institutions, and has established a strategic alliance with Accenture. The company operates internationally with offices in the UK, Brussels, New York, Boston, and Sydney.

Convertr

Series A in 2016
Convertr Media Limited operates Convertr, a cloud-based customer acquisition platform designed for brands, publishers, and agencies in both consumer and B2B markets. Founded in 2011 and headquartered in London, the platform facilitates multi-channel acquisition campaigns by leveraging customer data to enhance sales and provide real-time return on investment. It aids advertisers in driving campaigns, assists publishers in refining audience profiles to boost revenue, and enables agencies to automate client acquisition efforts while reducing workload. Convertr functions as an API-first data optimization tool, ensuring that marketing databases remain efficient by filtering and enhancing data to maintain accuracy and compliance. The platform integrates seamlessly with CRM, marketing automation, and programmatic advertising systems, providing comprehensive solutions for customer acquisition management and automated lead management.

SBD Automotive

Venture Round in 2016
SBD Automotive is an automotive technology platform that specializes in providing independent research, evaluation, and strategic services to car manufacturers. The company focuses on areas such as connected car telematics, vehicle security, and the development of autonomous vehicles and Advanced Driver-Assistance Systems (ADAS). SBD Automotive offers analytical reports, system usability testing, and end-user surveys, enabling the automotive industry to gain insights into technical and market trends. Additionally, they provide industry and market forecasts, as well as competitor benchmarking, to help clients navigate the complexities of automotive technology and enhance their decision-making processes. Through these services, SBD Automotive supports the development of safe and sustainable mobility solutions.

Achilles Therapeutics

Seed Round in 2016
Achilles Therapeutics Ltd. is a biopharmaceutical company based in London, United Kingdom, focused on developing patient-specific immunotherapies to treat cancer. Founded in 2016, the company creates personalized vaccines and T cell therapies that harness the immune system to target and eliminate cancer cells. By identifying truncal tumor neo-antigens and other cancer-specific markers, Achilles Therapeutics aims to develop next-generation therapies that selectively attack tumors while sparing healthy tissues. Currently, the company is conducting two clinical trials: the CHIRON trial for patients with non-small-cell lung cancer and the THETIS trial for those with recurrent or metastatic melanoma.

OLIM Ltd.

Acquisition in 2016
OLIM Ltd. is a privately owned investment management firm based in London, founded in 1986. The company specializes in managing equity mutual funds for a diverse clientele that includes charities, educational institutions, investment funds, individuals, family foundations, and pension funds. OLIM primarily focuses on the UK market, investing in value and dividend-yielding stocks of small-cap and mid-cap companies, while also engaging in public equity and fixed income investments globally. The firm emphasizes high-quality service, with its investment team managing UK equities and balanced portfolios, and it employs strategies in asset allocation, portfolio construction, stock selection, and risk management. As of November 2016, OLIM Ltd. operates as a subsidiary of Albion Ventures LLP.

Black Swan Data

Series B in 2016
Black Swan Data Limited is a London-based company that specializes in data integration and classification, data science, and predictive modeling. Founded in 2011, the company has developed a platform called Nest, which unifies and enriches data for visualization, allowing clients to gain insights into consumer demand influenced by various external factors, such as competitive activity and public events. Black Swan's technology focuses on analyzing both public and private data to predict consumer behavior accurately, helping brands identify untapped opportunities and enhance their marketing effectiveness. By leveraging AI-powered tools, the company aims to transform how businesses utilize data, ultimately creating better outcomes through informed decision-making and innovative solutions.

Relayware

Venture Round in 2016
Relayware is a global provider of Partner Relationship Management (PRM) software and services designed to enhance channel performance and accelerate revenue growth. The company's PRM system offers a suite of management, collaboration, and communication tools that improve partner effectiveness and engagement. By providing visibility into partner performance and delivering training resources, Relayware empowers organizations and their partners to achieve greater productivity. Its automated platform incorporates years of channel expertise, offering essential sales, marketing, and training resources, as well as partner portals that streamline revenue-generating processes. This focus on improving partner relationships ultimately helps businesses drive loyalty and optimize the performance of their indirect sales channels.

InCrowd Sports

Seed Round in 2016
InCrowd Sports Limited, based in London, specializes in developing mobile applications aimed at enhancing fan engagement within sports stadiums. Founded in 2014, the company provides a platform that delivers real-time content, match analysis, and interactive gamification tools, including quizzes and predictive games. This technology not only improves connectivity for fans during events but also allows sports clubs and sponsors to create mobile sponsorship inventory, enabling more effective engagement with audiences. InCrowd Sports combines expertise from various sectors to significantly enrich the in-stadia experience, fostering a deeper connection between fans and the sporting events they attend.

Grapeshot

Series C in 2016
Grapeshot Limited is a software company that specializes in providing marketing and advertising solutions through its Contextual Intelligence Platform. Founded in 2002 and headquartered in Cambridge, United Kingdom, Grapeshot offers tools for real-time targeting, audience discovery, and data enrichment, which aid brands, media agencies, and publishers in enhancing their advertising strategies. Its services include custom targeting, predictive targeting, brand safety, GDPR compliance, and campaign analytics. The platform enables users to improve media efficiency, increase customer engagement, and elevate brand perception by leveraging actionable data to identify revenue-driving behaviors. Grapeshot has received multiple accolades for its innovations, including recognition as a leading publisher tool and attribution solution. The company operates globally, with offices in major cities such as London, New York, Chicago, Los Angeles, Singapore, Toronto, Hong Kong, Shanghai, and Sydney. In 2018, Grapeshot became a subsidiary of Oracle Corporation.

Innovation Broking

Venture Round in 2015
Innovation Broking is an independent commercial insurance broker based in Watford, England. It specializes in providing corporate insurance broking services along with board-level risk management advice. The firm aims to assist companies and organizations in navigating complex risk landscapes, which have become increasingly intricate due to evolving legislation. By offering expert partnership at the board level, Innovation Broking helps clients enhance their risk management controls and develop a deeper understanding of their insurance needs.

Panaseer

Seed Round in 2015
Panaseer Limited develops a cloud-based cybersecurity intelligence platform that assists enterprise security teams in making informed risk decisions. Founded in 2014 and headquartered in London, with an office in New York, the company offers the Panaseer Security Data Lake, which provides real-time insights into an organization's assets, applications, users, and data sets. This platform identifies gaps in security controls and aligns them with industry standards while facilitating regulatory compliance. By ingesting data from various sources, both cloud-based and on-premises, Panaseer enables organizations to monitor and analyze their cybersecurity posture effectively. The platform automates reporting processes, tailoring insights for stakeholders at different levels, thereby enhancing decision-making across the organization. Security leaders utilize Panaseer’s capabilities to prioritize risks based on their potential impact on the business and optimize overall cyber hygiene practices.

Hussle

Series A in 2015
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Abcodia

Series B in 2015
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

Consensus

Seed Round in 2015
Consensus, Inc. offers a Software-as-a-Service application that streamlines B2B sales by facilitating agreement among stakeholders within the buying group. Its interactive demo automation platform personalizes video and document presentations, allowing each stakeholder to engage with the solution in a relevant manner. This approach effectively reduces sales cycles and enhances close rates. The company's Demolytics dashboard provides valuable analytics, enabling clients to identify and engage the entire buying committee by tracking their interests and interactions with the demo content. By using this platform, organizations across various sectors, including financial services, medical device manufacturing, and technology in the amusement park industry, can achieve faster purchase decisions compared to traditional sales methods. Founded in 2013 and headquartered in American Fork, Utah, Consensus was previously known as DemoChimp Inc. and rebranded in April 2016.

Aridhia

Venture Round in 2014
Aridhia Informatics Ltd. is a Glasgow-based company that specializes in providing biomedical informatics and analytic solutions aimed at enhancing the understanding and management of chronic diseases. Established in 2007, Aridhia offers a cloud-based platform that supports patient tracking, infection control, and long-term condition management. The company's services include clinical dashboards that present at-a-glance information for healthcare professionals, researchers, and policy makers, facilitating informed decision-making in clinical care. Through strategic partnerships with organizations such as GoPivotal and Glencoe Software, Aridhia aims to integrate patient, clinical, and genomic data to empower patients and inform public health initiatives. The multidisciplinary team at Aridhia collaborates closely with clinical experts to address significant health challenges, contributing to ongoing integrated care and advanced clinical research.

Exco inTouch

Venture Round in 2014
Exco inTouch Ltd is a provider of patient engagement and data capture solutions for clinical trials and healthcare programs, operating in the United Kingdom and internationally. Founded in 2004 and headquartered in Nottingham, the company offers a comprehensive application system called Gather, which facilitates two-way communication between patients, site managers, and study teams while ensuring compliance with study protocols. In addition to clinical trial support, Exco inTouch develops disease management programs that create condition-specific care plans, helping patients understand their conditions, adhere to treatment regimens, and effectively manage their health. The company's digital health platform has been applied across various therapeutic areas, including diabetes, dermatology, respiratory diseases, and haemophilia. As of December 2016, Exco inTouch operates as a subsidiary of eResearchTechnology, Inc.

The Charnwood Pub

Venture Round in 2014
The Charnwood Pub operates a collection of individual pubs across England, ranging from historic coaching inns with accommodations to charming country pubs. As free houses, these establishments are not bound to any specific brewery or brand, allowing them the flexibility to customize their offerings to meet the unique preferences of their local communities. The Charnwood Pub is dedicated to continuously enhancing the experience at each location, valuing feedback from patrons to ensure that their needs are met. With a focus on delivering quality food and a welcoming atmosphere, The Charnwood Pub aims to create a distinctive and enjoyable environment for its guests.

Mirada Medical

Venture Round in 2014
Mirada Medical Limited specializes in the development of medical imaging software applications tailored for radiology, molecular imaging, radiation oncology, and multidisciplinary meetings in hospitals, imaging centers, and cancer centers. Founded in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, the company offers a range of innovative software solutions. These include Mirada XD, which serves various medical fields such as nuclear medicine and cardiology; DLCExpert, a clinical application that provides automated organ-at-risk contouring; and Mirada IM, which supports interventional medicine products, including radioembolization therapy. Mirada Medical's products are marketed through direct sales and distributors, aiming to enhance the diagnosis, management, and treatment of cancer and other diseases worldwide.

Elateral Ltd.

Venture Round in 2014
Elateral Ltd. specializes in intelligent multi-channel content generation and customization solutions for clients in the United Kingdom and beyond. The company has developed the Elateral Marketing Services Cloud, a cloud-based platform that allows marketing organizations to source, customize, and distribute content in various formats and languages. Its offerings include professional services such as consulting, implementation, template development, and asset management, alongside solutions for customized point-of-sale materials, promotional packaging, and campaign visibility. Elateral's technology supports a marketing trend known as Mass Multi-Channel Customization, which enables marketers to deliver relevant content effectively across numerous channels. The company serves a diverse clientele, including brand marketers in consumer goods, hi-tech, and automotive industries, as well as design agencies and local marketing teams. Founded in 1995 and headquartered in Farnham, United Kingdom, Elateral Ltd. is a subsidiary of Elateral Group Limited.

KERN Ventures

Venture Round in 2014
KERN Ventures is a venture building accelerator based in Malaysia that focuses on pre-seed to seed stage investments. The firm aims to initiate, co-create, and accelerate startups by providing not only funding but also hands-on operational guidance. KERN Ventures targets high-growth sectors, including on-demand services, fintech, and e-commerce, to develop innovative business solutions. The accelerator operates on a model where it invests in groups of five promising ideas biannually, seeking to recruit top talent to bring these concepts to fruition.

Chonais Holdings

Venture Round in 2014
Chonais Holdings is a renewable energy company based in London, United Kingdom.

Haemostatix

Venture Round in 2014
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Abcodia

Venture Round in 2014
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

MyMeds&Me

Venture Round in 2014
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry. The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.

Dysis Medical

Venture Round in 2014
Dysis Medical Ltd. is a medical device company based in Edinburgh, United Kingdom, specializing in the design, development, manufacture, and marketing of imaging systems for the non-invasive detection of cancerous and pre-cancerous lesions. The company's flagship product, the DYSIS Colposcope, utilizes patented optical and software techniques to scan the cervix, measure the aceto-whitening reaction, and present findings in an intuitive color-coded map. This technology aids medical practitioners in the early detection, diagnosis, and monitoring of cervical neoplasia, as well as in identifying biopsy sites. In addition to the colposcope, Dysis Medical offers various accessories, including disposable and reusable specula, diathermy loops, and coagulation balls, along with software for data management and image analysis. Founded in 2002 and previously known as FORTH Photonics Limited until its rebranding in 2011, Dysis Medical also operates sales offices in Tampa, Florida, and Athens, Greece.

Green Highland Renewables

Venture Round in 2014
Green Highland Renewables (GHR) focuses on the development of small-scale run-of-river hydro projects, typically ranging from 50 kW to 2 MW. The company offers comprehensive support to landowners and communities, guiding them through the entire process of design, procurement, and operation of hydropower projects. GHR aims to facilitate sustainable energy solutions while contributing to Scotland's commitment to addressing climate change. Their expertise encompasses innovative development strategies, electrical network development, directional drilling, pipeline installations, and lifecycle management, all designed to enable clients to harness hydropower for electricity generation effectively.

Perpetuum

Series C in 2014
Perpetuum Ltd. specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 and based in Southampton, United Kingdom, the company focuses on creating battery-free vibration energy harvesters and wireless sensor nodes for various applications, including rail, oil and gas, chemicals, power generation, and water treatment. Perpetuum's technology converts mechanical vibrations into electrical energy, enabling autonomous, maintenance-free wireless sensors that monitor equipment conditions and processes. This innovative approach enhances efficiency and safety in fleet management and services, particularly within the rail industry. As a technology spin-off from the University of Southampton, Perpetuum has established itself as a leader in vibration energy harvesting, providing practical solutions for wireless automation.

Relayware

Venture Round in 2014
Relayware is a global provider of Partner Relationship Management (PRM) software and services designed to enhance channel performance and accelerate revenue growth. The company's PRM system offers a suite of management, collaboration, and communication tools that improve partner effectiveness and engagement. By providing visibility into partner performance and delivering training resources, Relayware empowers organizations and their partners to achieve greater productivity. Its automated platform incorporates years of channel expertise, offering essential sales, marketing, and training resources, as well as partner portals that streamline revenue-generating processes. This focus on improving partner relationships ultimately helps businesses drive loyalty and optimize the performance of their indirect sales channels.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

AMS Sciences

Seed Round in 2014
AMS Sciences

Proveca

Venture Round in 2014
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

Taunton Nursing Home

Venture Round in 2014
Taunton Nursing Home is a non-profit healthcare facility that provides services for elders. Taunton Nursing Home provides short-term rehab services such as speech, occupational, and physical therapies. It provides ADL assistance as well as medication administration for its long-term residents. It also offers many other services, including social services; dental, podiatry, and vision care; chaplain services; and more. Taunton Nursing Home is based in Taunton, Massachusetts, United States.

Chonais Holdings

Venture Round in 2014
Chonais Holdings is a renewable energy company based in London, United Kingdom.

Cisiv

Venture Round in 2014
Cisiv Ltd is a technology solutions provider focused on serving global pharmaceutical and biotech companies, research organizations, and academic institutions. The company specializes in its Baseline Plus platform, a web-based data capture system designed for non-interventional studies. This platform simplifies the execution of complex, large-scale multinational studies by enhancing data quality and workflow through features that support data entry, online community engagement, and translation capabilities. By enabling researchers and medical professionals to extract meaningful patient data, Cisiv facilitates deeper insights into the real-world application of medical treatments and products. Established in 1995, Cisiv is headquartered in Kingston upon Thames, United Kingdom.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

OmPrompt

Venture Round in 2014
OmPrompt Limited is a data management company based in Abingdon, United Kingdom, specializing in supply chain solutions. Established in 2002 and formerly known as Sparhurst Limited, the company offers an Order Management Platform that facilitates EDI connectivity and automates non-EDI document processes. This platform enhances visibility and control within order-to-cash and procure-to-pay processes, enabling suppliers to connect with any trading partner and manage various document formats. OmPrompt's advanced machine learning technology enables the automation of order processing, complaints, and fulfillment across multi-enterprise environments, allowing clients to effectively handle both structured and unstructured data from customers and suppliers. The company serves notable clients, including Unilever, BACARDI, Nestle, Kellogg's, and Targus, aiming to improve operational efficiency and customer experience while reducing costs.

Elateral Ltd.

Venture Round in 2014
Elateral Ltd. specializes in intelligent multi-channel content generation and customization solutions for clients in the United Kingdom and beyond. The company has developed the Elateral Marketing Services Cloud, a cloud-based platform that allows marketing organizations to source, customize, and distribute content in various formats and languages. Its offerings include professional services such as consulting, implementation, template development, and asset management, alongside solutions for customized point-of-sale materials, promotional packaging, and campaign visibility. Elateral's technology supports a marketing trend known as Mass Multi-Channel Customization, which enables marketers to deliver relevant content effectively across numerous channels. The company serves a diverse clientele, including brand marketers in consumer goods, hi-tech, and automotive industries, as well as design agencies and local marketing teams. Founded in 1995 and headquartered in Farnham, United Kingdom, Elateral Ltd. is a subsidiary of Elateral Group Limited.

Blackbay

Venture Round in 2014
Blackbay Ltd. is a provider of mobile enterprise solutions tailored for the transport and logistics industry. Founded in 2004 and headquartered in Derby, United Kingdom, the company develops various cloud-based applications, including Delivery Connect, which enables real-time freight movement management, and No Trucking Worries, designed for drivers and dispatchers. Additionally, Blackbay offers Expect, a solution that enhances communication and management during delivery and collection processes. The company serves diverse sectors, including postal services, courier operations, and manufacturing, with a customer base that includes notable names such as Royal Mail and DHL. Blackbay has empowered over 55,000 mobile workers globally, facilitating efficient supply chain and field service operations. Formerly known as iTouch Business Mobility, Blackbay operates as a subsidiary of BluJay Solutions Ltd.

Berkley Care Group

Venture Round in 2014
Berkley Care Group Ltd is a provider of specialist care services for elderly individuals, operating a selection of luxury care homes in the United Kingdom. Founded in 2010 and headquartered in Warwick, the company manages facilities such as Groveland Park, Shinfield View, Cumnor Hill House, Ryefield Court, and Leycester House. Berkley Care Group is recognized for its commitment to high-quality care, with three of its five accredited homes being rated as 'Outstanding' by the Care Quality Commission (CQC). In addition to operating care homes, the company also engages in the design and construction of new facilities, ensuring they meet the specific needs of their residents, particularly in areas such as nursing and dementia care.

Active Lives Care

Venture Round in 2014
Active Lives Care was incorporated in 2013 and is based in London, United Kingdom.

Ryefield Court

Venture Round in 2014
Ryefield Court Care Limited owns and operates a residential care home for the elderly. The company was incorporated in 2012 and is based in Hillingdon, United Kingdom.

Dysis Medical

Venture Round in 2014
Dysis Medical Ltd. is a medical device company based in Edinburgh, United Kingdom, specializing in the design, development, manufacture, and marketing of imaging systems for the non-invasive detection of cancerous and pre-cancerous lesions. The company's flagship product, the DYSIS Colposcope, utilizes patented optical and software techniques to scan the cervix, measure the aceto-whitening reaction, and present findings in an intuitive color-coded map. This technology aids medical practitioners in the early detection, diagnosis, and monitoring of cervical neoplasia, as well as in identifying biopsy sites. In addition to the colposcope, Dysis Medical offers various accessories, including disposable and reusable specula, diathermy loops, and coagulation balls, along with software for data management and image analysis. Founded in 2002 and previously known as FORTH Photonics Limited until its rebranding in 2011, Dysis Medical also operates sales offices in Tampa, Florida, and Athens, Greece.

Elateral Ltd.

Venture Round in 2014
Elateral Ltd. specializes in intelligent multi-channel content generation and customization solutions for clients in the United Kingdom and beyond. The company has developed the Elateral Marketing Services Cloud, a cloud-based platform that allows marketing organizations to source, customize, and distribute content in various formats and languages. Its offerings include professional services such as consulting, implementation, template development, and asset management, alongside solutions for customized point-of-sale materials, promotional packaging, and campaign visibility. Elateral's technology supports a marketing trend known as Mass Multi-Channel Customization, which enables marketers to deliver relevant content effectively across numerous channels. The company serves a diverse clientele, including brand marketers in consumer goods, hi-tech, and automotive industries, as well as design agencies and local marketing teams. Founded in 1995 and headquartered in Farnham, United Kingdom, Elateral Ltd. is a subsidiary of Elateral Group Limited.

Gracewell Healthcare

Venture Round in 2014
Gracewell Healthcare is a residential care home operator based in the United Kingdom, specializing in providing personalized care services for seniors and the elderly. The company manages a network of care homes that offer a variety of services, including nursing care, dementia care, respite care, and stroke rehabilitation. Gracewell Healthcare emphasizes the importance of comfort and social interaction, providing luxury facilities equipped with amenities designed to enhance the quality of life for residents. With a commitment to round-the-clock care, the organization aims to meet the diverse needs of its residents in a supportive and caring environment.

Green Highland Renewables

Venture Round in 2014
Green Highland Renewables (GHR) focuses on the development of small-scale run-of-river hydro projects, typically ranging from 50 kW to 2 MW. The company offers comprehensive support to landowners and communities, guiding them through the entire process of design, procurement, and operation of hydropower projects. GHR aims to facilitate sustainable energy solutions while contributing to Scotland's commitment to addressing climate change. Their expertise encompasses innovative development strategies, electrical network development, directional drilling, pipeline installations, and lifecycle management, all designed to enable clients to harness hydropower for electricity generation effectively.

Mirada Medical

Venture Round in 2014
Mirada Medical Limited specializes in the development of medical imaging software applications tailored for radiology, molecular imaging, radiation oncology, and multidisciplinary meetings in hospitals, imaging centers, and cancer centers. Founded in 1999 and headquartered in Oxford, United Kingdom, with an additional office in Denver, Colorado, the company offers a range of innovative software solutions. These include Mirada XD, which serves various medical fields such as nuclear medicine and cardiology; DLCExpert, a clinical application that provides automated organ-at-risk contouring; and Mirada IM, which supports interventional medicine products, including radioembolization therapy. Mirada Medical's products are marketed through direct sales and distributors, aiming to enhance the diagnosis, management, and treatment of cancer and other diseases worldwide.

Bravo Inns

Venture Round in 2014
In TV soapland, pubs like the Rovers Return are at the very heart of their communities. In real life, the community pub is more important than that! Nothing defines a community better than its community pub. And at Bravo Inns Limited they’re committed to breathing life back into community pubs throughout their area. Based in Warrington and led by a small, dedicated and highly experienced management team, they now manage 35 community pubs in North Cheshire, Greater Manchester, Lancashire and Cumbria. Many were closed before they stepped in. Their success is due to strictly following a business model based on tried and tested core values. Take a tour though their site to discover more about Bravo Inns.

Grapeshot

Venture Round in 2014
Grapeshot Limited is a software company that specializes in providing marketing and advertising solutions through its Contextual Intelligence Platform. Founded in 2002 and headquartered in Cambridge, United Kingdom, Grapeshot offers tools for real-time targeting, audience discovery, and data enrichment, which aid brands, media agencies, and publishers in enhancing their advertising strategies. Its services include custom targeting, predictive targeting, brand safety, GDPR compliance, and campaign analytics. The platform enables users to improve media efficiency, increase customer engagement, and elevate brand perception by leveraging actionable data to identify revenue-driving behaviors. Grapeshot has received multiple accolades for its innovations, including recognition as a leading publisher tool and attribution solution. The company operates globally, with offices in major cities such as London, New York, Chicago, Los Angeles, Singapore, Toronto, Hong Kong, Shanghai, and Sydney. In 2018, Grapeshot became a subsidiary of Oracle Corporation.

Hussle

Venture Round in 2014
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Silent Herdsman

Venture Round in 2014
Silent Herdsman’s vision is to be the leading global provider of predictive analytics software for dairy and beef farmers, that improves herd performance, business efficiency and animal welfare. Crucially, the collar triggers an alert to farmers when cows are on heat, providing farmers with advanced knowledge to activate insemination at critical times. This in turn enables them to produce more milk from the impregnated cows and increase their yields from each herd. The Silent Herdsman® triggers its alert via wireless technology to any mobile device such as a farmer’s mobile phone, tablet or laptop. Uniquely, its wireless technology can travel over long distances meaning it is suitable for farms hosting 100 to 20,000 cows. Its unique differentiator includes monitoring herds across large geographical distances on farms hosting several thousand beef or dairy cows.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Active Lives Care

Venture Round in 2014
Active Lives Care was incorporated in 2013 and is based in London, United Kingdom.

Egress

Series A in 2014
Egress Software Technologies Ltd. specializes in cloud-based email and file encryption solutions aimed at securely sharing confidential information across various sectors, including public services, healthcare, education, and financial services. Founded in 2007 and headquartered in London, the company offers a range of products such as desktop, mobile, and gateway encryption, as well as secure web forms. Its human-layer security platform employs advanced contextual machine learning and encryption technologies to prevent data breaches, providing organizations with tools to manage unstructured data effectively. Egress aims to enhance email security, ensuring compliance with regulatory standards and improving productivity for small, mid-sized, and enterprise-level organizations. With offices in London, Sheffield, Boston, and Toronto, Egress serves a global clientele, including individual users and large commercial entities.

Haemostatix

Venture Round in 2014
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Street By Street Solar

Venture Round in 2014
Street By Street Solar offers rooftop solar installations with a sustainable source of power.

Abcodia

Venture Round in 2014
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

Mi-Pay

Post in 2014
Mi-Pay delivers outsourced payment solutions to digital e-commerce clients, primarily in the mobile sector. Its clientele is comprised of mobile operators, virtual operators, prepaid card providers, financial institutions, and media companies. The company also provides a portfolio of client branded, mobile payment services for mobile operators, financial service providers, utility companies, and media owners from their offices in the U.K., Romania, U.A.E., and India. Its infrastructure allows end customers to top-up using multiple payment methods such as credit or debit card, PaypalTM, bank transfer, and direct debit across all channels. Mi-Pay was founded in 2003.

Taunton Nursing Home

Venture Round in 2014
Taunton Nursing Home is a non-profit healthcare facility that provides services for elders. Taunton Nursing Home provides short-term rehab services such as speech, occupational, and physical therapies. It provides ADL assistance as well as medication administration for its long-term residents. It also offers many other services, including social services; dental, podiatry, and vision care; chaplain services; and more. Taunton Nursing Home is based in Taunton, Massachusetts, United States.

Green Highland Renewables

Venture Round in 2013
Green Highland Renewables (GHR) focuses on the development of small-scale run-of-river hydro projects, typically ranging from 50 kW to 2 MW. The company offers comprehensive support to landowners and communities, guiding them through the entire process of design, procurement, and operation of hydropower projects. GHR aims to facilitate sustainable energy solutions while contributing to Scotland's commitment to addressing climate change. Their expertise encompasses innovative development strategies, electrical network development, directional drilling, pipeline installations, and lifecycle management, all designed to enable clients to harness hydropower for electricity generation effectively.

Cisiv

Venture Round in 2013
Cisiv Ltd is a technology solutions provider focused on serving global pharmaceutical and biotech companies, research organizations, and academic institutions. The company specializes in its Baseline Plus platform, a web-based data capture system designed for non-interventional studies. This platform simplifies the execution of complex, large-scale multinational studies by enhancing data quality and workflow through features that support data entry, online community engagement, and translation capabilities. By enabling researchers and medical professionals to extract meaningful patient data, Cisiv facilitates deeper insights into the real-world application of medical treatments and products. Established in 1995, Cisiv is headquartered in Kingston upon Thames, United Kingdom.

Erin Solar

Venture Round in 2013
Erin Solar is a commercial solar panel management company. Erin Solar provide commercial landlords with solar photovoltaic solutions in Northern Ireland.

Relayware

Series A in 2013
Relayware is a global provider of Partner Relationship Management (PRM) software and services designed to enhance channel performance and accelerate revenue growth. The company's PRM system offers a suite of management, collaboration, and communication tools that improve partner effectiveness and engagement. By providing visibility into partner performance and delivering training resources, Relayware empowers organizations and their partners to achieve greater productivity. Its automated platform incorporates years of channel expertise, offering essential sales, marketing, and training resources, as well as partner portals that streamline revenue-generating processes. This focus on improving partner relationships ultimately helps businesses drive loyalty and optimize the performance of their indirect sales channels.

Helveta

Venture Round in 2013
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Dysis Medical

Venture Round in 2013
Dysis Medical Ltd. is a medical device company based in Edinburgh, United Kingdom, specializing in the design, development, manufacture, and marketing of imaging systems for the non-invasive detection of cancerous and pre-cancerous lesions. The company's flagship product, the DYSIS Colposcope, utilizes patented optical and software techniques to scan the cervix, measure the aceto-whitening reaction, and present findings in an intuitive color-coded map. This technology aids medical practitioners in the early detection, diagnosis, and monitoring of cervical neoplasia, as well as in identifying biopsy sites. In addition to the colposcope, Dysis Medical offers various accessories, including disposable and reusable specula, diathermy loops, and coagulation balls, along with software for data management and image analysis. Founded in 2002 and previously known as FORTH Photonics Limited until its rebranding in 2011, Dysis Medical also operates sales offices in Tampa, Florida, and Athens, Greece.

MyMeds&Me

Venture Round in 2013
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry. The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.

Proveca

Venture Round in 2013
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

Hussle

Seed Round in 2013
Hussle is the smart new way to fit fitness into your life. We partner with amazing gyms across the UK. When you Hussle, you can go to any of these gyms. There are no contracts, no inductions, no sign-up fees. Just thousands of gyms, pools and spas – wherever you are, whenever you want to go. So when you Hussle, you can make fitness a part of your day, not a pause in it. Hussle. Make life work out.

Haemostatix

Venture Round in 2012
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.

Xceleron

Venture Round in 2012
Xceleron, founded in 1997 in York, UK, and now based in Germantown, Maryland, specializes in bioanalytical accelerator mass spectrometry (AMS) services to enhance drug development. The company pioneered techniques for human microdosing and microtracing, focusing on the pharmacokinetics and metabolism of developmental drugs during early clinical trial phases. Xceleron's services include micro-dosing, preclinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. Their expertise is particularly valuable given the complexity of modern small molecules, which often exhibit low solubility and lengthy half-lives, necessitating early pharmacokinetic characterization to improve the cost-effectiveness of clinical development. Through a commitment to integrity and collaboration, Xceleron aims to accelerate the delivery of life-changing products to the market.

Hilson Moran

Venture Round in 2012
Hilson Moran provides consultancy in building services, sustainability, facilities management and other services and is firmly established as a leading service engineer to commercial office, retail, leisure, hotel and residential projects.

Helveta

Venture Round in 2011
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Abcodia

Venture Round in 2011
Abcodia Ltd. is a company focused on the discovery and validation of molecular biomarkers for disease diagnosis and screening. Established in 2010 and based in London, it offers the Roca Test, a solution for the early detection of ovarian cancer, available to customers across various states in the United States as well as in the United Kingdom. Abcodia utilizes a unique longitudinal serum biobank and collaborates with prominent institutions and diagnostic companies to enhance the diagnostic development process. Through these efforts, the company aims to improve disease detection and contribute to better health outcomes.

Celoxica

Venture Round in 2011
Celoxica Limited, based in Abingdon, United Kingdom, provides hardware-accelerated market data access and order execution solutions aimed at the financial services industry. Founded in 1996, the company specializes in ultra-low latency trading services, catering to the advanced trading community, including trading firms and banks engaged in high-frequency trading, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica offers a range of market data feed handlers covering major U.S. and European equities, options, futures, and foreign exchange markets. The company facilitates seamless connectivity for brokers and clients by managing inbound FIX, credit checks, and outbound native protocols to execution venues. With additional offices in Chicago and New York, Celoxica remains focused on meeting the growing demands for speed and efficiency in electronic trading.

Radnor House

Venture Round in 2010
Radnor House School (Holdings) Limited is an independent co-educational day school located in Twickenham, United Kingdom. Established in 2010, the school offers a supportive learning environment for both boys and girls, focusing on delivering a comprehensive education that fosters intellectual, moral, social, physical, and spiritual development. Radnor House also emphasizes inclusivity by providing specialized support for students with special education needs and disabilities through its dedicated SEND program. The institution aims to equip its students with the necessary qualifications, skills, and personal qualities for their future endeavors.

Masters Pharmaceutical Inc

Venture Round in 2010
Masters Pharmaceutical is a pharmaceuticals company offering pharmaceutical and medical products.

Oxsensis

Series C in 2010
Oxsensis Ltd. is a manufacturer of non-electrical optical sensors designed for extreme environments, focusing on applications in aerospace, power generation, oil and gas, and nuclear industries. Founded in 2003 and headquartered in Didcot, United Kingdom, the company specializes in optical pressure sensor systems, temperature transducers, and optical accelerometers. Its product lineup includes the Wave-Phire Dynamic Pressure Transducer for harsh atmospheres, the i-Phire 4 Channel Optical Interrogator Unit for converting optical signals into voltage signals, and S-Phire software for combustion monitoring. These sensors provide high sensitivity and immunity to electromagnetic interference, optimizing performance in demanding conditions. Oxsensis also supports various markets, including energy production, emissions monitoring, and high-temperature equipment health monitoring, with additional offices in the United States, Russia, China, and Japan.

Orchard Portman House Hospital

Acquisition in 2010
Orchard Portman House Hospital is a mental health hospital and provides care and rehabilitative support of people.

Rostima

Venture Round in 2009
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Rostima

Seed Round in 2009
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Helveta

Funding Round in 2009
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Rostima

Venture Round in 2009
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Helveta

Venture Round in 2009
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Rostima

Venture Round in 2008
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.